Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression.
https://psychedelicspotlight.com/wp-content/uploads/2021/03/drug-psychedelic-spotlight.jpg6671000Jill Ettingerhttp://psychedelicspotlight.com/wp-content/uploads/2021/11/Psych_Sptlgt_Horizontal1-300x38.pngJill Ettinger2021-03-23 10:00:002021-03-23 04:46:31Big Pharma Giant Merck Partners With Psychedelic Research Company Novamind
Get a roundup of Psychedelic news stories in your inbox
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.